208 related articles for article (PubMed ID: 24350712)
21. Cytochrome P450 2A6 and other human P450 enzymes in the oxidation of flavone and flavanone.
Kakimoto K; Murayama N; Takenaka S; Nagayoshi H; Lim YR; Kim V; Kim D; Yamazaki H; Komori M; Guengerich FP; Shimada T
Xenobiotica; 2019 Feb; 49(2):131-142. PubMed ID: 29310511
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of sulfinpyrazone sulfide and sulfinpyrazone by human liver microsomes and cDNA-expressed cytochrome P450s.
He M; Rettie AE; Neal J; Trager WF
Drug Metab Dispos; 2001 May; 29(5):701-11. PubMed ID: 11302937
[TBL] [Abstract][Full Text] [Related]
23. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
Yamazaki H; Shimada T
Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
[TBL] [Abstract][Full Text] [Related]
24. Drug interactions of thalidomide with midazolam and cyclosporine A: heterotropic cooperativity of human cytochrome P450 3A5.
Okada Y; Murayama N; Yanagida C; Shimizu M; Guengerich FP; Yamazaki H
Drug Metab Dispos; 2009 Jan; 37(1):18-23. PubMed ID: 18948377
[TBL] [Abstract][Full Text] [Related]
25. Mechanism-based inactivation of cytochrome P450s 1A2 and 3A4 by dihydralazine in human liver microsomes.
Masubuchi Y; Horie T
Chem Res Toxicol; 1999 Oct; 12(10):1028-32. PubMed ID: 10525281
[TBL] [Abstract][Full Text] [Related]
26. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.
Yamazaki H; Shaw PM; Guengerich FP; Shimada T
Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
[TBL] [Abstract][Full Text] [Related]
28. Dehydrogenation of indoline by cytochrome P450 enzymes: a novel "aromatase" process.
Sun H; Ehlhardt WJ; Kulanthaivel P; Lanza DL; Reilly CA; Yost GS
J Pharmacol Exp Ther; 2007 Aug; 322(2):843-51. PubMed ID: 17502430
[TBL] [Abstract][Full Text] [Related]
29. Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver.
Shou M; Martinet M; Korzekwa KR; Krausz KW; Gonzalez FJ; Gelboin HV
Pharmacogenetics; 1998 Oct; 8(5):391-401. PubMed ID: 9825831
[TBL] [Abstract][Full Text] [Related]
30. Simulation of Human Plasma Concentrations of Thalidomide and Primary 5-Hydroxylated Metabolites Explored with Pharmacokinetic Data in Humanized TK-NOG Mice.
Nishiyama S; Suemizu H; Shibata N; Guengerich FP; Yamazaki H
Chem Res Toxicol; 2015 Nov; 28(11):2088-90. PubMed ID: 26492539
[TBL] [Abstract][Full Text] [Related]
31. Differential N-demethylation of l-alpha-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4.
Neff JA; Moody DE
Biochem Biophys Res Commun; 2001 Jun; 284(3):751-6. PubMed ID: 11396966
[TBL] [Abstract][Full Text] [Related]
32. In vivo formation of a glutathione conjugate derived from thalidomide in humanized uPA-NOG mice.
Yamazaki H; Suemizu H; Igaya S; Shimizu M; Shibata N; Nakamura M; Chowdhury G; Guengerich FP
Chem Res Toxicol; 2011 Mar; 24(3):287-9. PubMed ID: 21299192
[TBL] [Abstract][Full Text] [Related]
33. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
Guengerich FP; Wilkey CJ; Phan TTN
J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
[TBL] [Abstract][Full Text] [Related]
34. Oxidation of nonionic detergents by cytochrome P450 enzymes.
Hosea NA; Guengerich FP
Arch Biochem Biophys; 1998 May; 353(2):365-73. PubMed ID: 9606971
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
36. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
[TBL] [Abstract][Full Text] [Related]
37. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives.
Notley LM; Crewe KH; Taylor PJ; Lennard MS; Gillam EM
Chem Res Toxicol; 2005 Oct; 18(10):1611-8. PubMed ID: 16533026
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
Guengerich FP; Johnson WW
Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
[TBL] [Abstract][Full Text] [Related]
40. 5'-OH-thalidomide, a metabolite of thalidomide, inhibits angiogenesis.
Price DK; Ando Y; Kruger EA; Weiss M; Figg WD
Ther Drug Monit; 2002 Feb; 24(1):104-10. PubMed ID: 11805730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]